- 
Reuters - Eli Lilly and Co has agreed to acquire ImClone Systems Inc for $6.5 billion, outbidding Bristol-Myers Squibb Co and potentially bringing to a close one of the most colorful corporate sagas in biotech history.
- Reuters - Asthma patients who are black tend to have more severe disease than asthma patients who are white, leading to more asthma control problems, higher rates of emergency department visits, and overall worse quality of life. These findings point to genetic differences that lead to poor responses to drug therapy as the source of these racial disparities. - 
AFP - US pharmaceutical company Eli Lilly said Monday it had agreed a takeover worth 6.5 billion dollars with biotech firm ImClone, which is also a target for rival Bristol-Myers Squibb (BMS).
- Reuters - Scientists have pinpointed three genes related to the high blood levels of uric acid that cause gout in a step that could help identify people at special risk for this common and painful type of arthritis. - HealthDay - TUESDAY, Sept. 30(HealthDay News) -- Three genes may raise risks for
painful gout by up to 40 times, researchers report. - 
AFP - The discovery of a genetic link between obesity and colon cancer may pave the way for more effective screening tests for the disease, according to a study published Tuesday.
- 
AFP - Scientists in Japan have identified a genetic mutation linked to narcolepsy, a disease that can cause someone to doze off in mid-sentence or behind the wheel of a car, a study released Sunday reports.
- LiveScience.com - This Behind the Scenes article was provided to LiveScience in partnership with the National Science Foundation. - Reuters - The cost of specialty biotech drugs increased 8.7 percent last year in the United States, three times the rate of inflation, according to AARP, a Washington-based group representing the elderly. - 
HealthDay - THURSDAY, Sept. 25 (HealthDay News) -- Researchers report that
they have sidestepped a major technical hurdle in the generation of
pluripotent stem cells from adult cells.
